ArticleTherapeutic advances in respiratory disease

Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam.

Van Luan Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.